FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For U.S. Sales


BLOOMINGTON, Ind. -- Federal clearance to market a hydrophilic-coated version of Cook Critical Care's antimicrobial central venous catheter means U.S. clinicians now can bring Cook Spectrum's superior properties, which help provide protection against catheter-elated bloodstream infections, to patients posing the greatest catheter placement challenges.


The new Cook Spectrum Glide Minocycline/Rifampin Impregnated Catheters, which received Food and Drug Administration (FDA) clearance this month, will be marketed immediately to U.S. critical care facilities, Cook officials announced.


Cook Spectrum catheters employ the company's patented antimicrobial impregnation process that helps provide protection on both the internal and external surfaces of the catheter. Spectrum catheters have been shown to be up to 12 times more likely to resist life-threatening catheter-related infections compared to chlorhexadine/silver sulfadiazine-coated catheters. With its new, highly lubricious hydrophilic surface, Cook Spectrum Glide central venous catheters offer an unparalleled combination of patient safety and ease of use.


"With the Cook Spectrum Glide line of catheters, Cook now offers physicians the best of both worlds," explained Bruce Gingles, vice president of Cook Critical Care. "Spectrum antimicrobial catheters impregnated with minocycline and rifampin show superior results in reducing the risks to patients from catheter-related infections and sparing hospitals the enormous cost of treating these patients. Now, with Cook's unique new Spectrum Glide product, no physician will ever again need to choose between using a catheter they can place easily or using one that provides the highest level of protection against catheter-related bloodstream infection."


Source: Cook Critical Care

Related Videos
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Related Content